Is Radiopharm Theranostics Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Radiopharm Theranostics Ltd (RAD.AX) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Radiopharm Theranostics Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Radiopharm Theranostics Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Radiopharm Theranostics Ltd?

Muslim investors may consider investing in Radiopharm Theranostics Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Radiopharm Theranostics Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Radiopharm Theranostics Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Radiopharm Theranostics Ltd updated?

The Shariah compliance status of Radiopharm Theranostics Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Radiopharm Theranostics Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Radiopharm Theranostics Ltd?

You can check the latest Shariah compliance status of Radiopharm Theranostics Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

RAD.AX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: April 19, 2026

Report Source: 2026 2nd Quarter Report

Radiopharm Theranostics Ltd. Stock Analysis RAD.AX

Australia Health Care Micro Cap Report: Q2, 2026

Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. The company is headquartered in Melbourne, Victoria and currently employs 14 full-time employees. The company went IPO on 2021-11-25. The firm has a pipeline of highly differentiated platform technologies spanning peptides, small molecules and monoclonal antibodies for use in cancer. The clinical program includes one Phase II and three Phase I trials in a variety of solid tumor cancers including lung, breast, and brain. Its technologies include Nano-mAbs, Pivalate, AVB6 Integrin, PSA-mAb, and PTPu. Nano-mAbs is a novel radiopharmaceutical platform made using genetic engineered camelid derived single domain antibodies (sdAb) labelled with a radioisotope of therapeutic radiation. Pivalate is an 18F-FPIA radiotracer, based on a short chain carbohydrate which utilizes the early steps of fatty acid oxidation.

Key Statistics of Radiopharm Theranostics Ltd (RAD.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.02AUD0.02

Today's Open

AUD0.02

Volume

4.56M

P/E Ratio (TTM)

52 Week Range

AUD0.02AUD0.04

Market Cap

70.88M

Avg. Volume

2.58M

Dividend Yield

Financial Metrics & Statements of Radiopharm Theranostics Ltd (RAD.AX)

FAQ's for Radiopharm Theranostics Ltd (RAD.AX)

According to Musaffa’s Shariah screening methodology, Radiopharm Theranostics Ltd (RAD.AX) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.